2/4
07:05 am
uncy
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
Medium
Report
Unicycive Therapeutics to Participate in a Fireside Chat at Guggenheim’s Emerging Outlook: Biotech Summit
1/29
04:16 pm
uncy
Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile [Seeking Alpha]
High
Report
Unicycive: 'Buy' Rating On NDA Resubmission OLC And Potential Best-In-Class Profile [Seeking Alpha]
1/29
09:15 am
uncy
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Medium
Report
UPDATE - Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
1/29
07:31 am
uncy
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission [Yahoo! Finance]
1/29
07:05 am
uncy
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Medium
Report
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
12/30
08:42 am
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Medium
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/29
04:27 pm
uncy
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
Medium
Report
Unicycive resubmits NDA for hyperphosphatemia asset [Seeking Alpha]
12/29
07:47 am
uncy
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
Medium
Report
Companies Like Unicycive Therapeutics (NASDAQ:UNCY) Are In A Position To Invest In Growth [Yahoo! Finance]
12/29
07:21 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
12/29
07:05 am
uncy
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Medium
Report
Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
12/10
11:42 am
uncy
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]
Low
Report
2025 Forbes Healthcare Summit | How To Make Medicine Personal [Forbes]
11/25
01:58 pm
uncy
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Unicycive Therapeutics (NASDAQ:UNCY) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
08:01 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December [Yahoo! Finance]
11/25
07:05 am
uncy
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
Medium
Report
Unicycive Therapeutics to Participate in Upcoming Investor Events in December
11/18
06:27 am
uncy
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
Low
Report
Retail investors who hold 48% of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) gained 23%, institutions profited as well [Yahoo! Finance]
11/12
08:19 am
uncy
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
Medium
Report
Unicycive Therapeutics GAAP EPS of -$0.46 beats by $0.07 [Seeking Alpha]
11/12
07:35 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/12
07:05 am
uncy
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
Unicycive Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update